Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine: interim guidance, 17 March 2021

Simple item page
dc.coverageGeneva
dc.creatorWorld Health Organization
dc.date2021-03-17T10:11:06Z
dc.date2021-03-17T13:00:00Z
dc.date2021-03-17
dc.date.accessioned2026-08-03T10:52:49Z
dc.description6 p.
dc.descriptionThe Portuguese version is published by PAHO: https://iris.paho.org/handle/10665.2/53367
dc.formatapplication/pdf
dc.formatapplication/pdf
dc.formatapplication/pdf
dc.identifierWHO/2019-nCoV/vaccines/SAGE_recommendation/Ad26.COV2.S/2021.1
dc.identifierhttps://iris.who.int/handle/10665/340203
dc.identifier.urihttps://repo.dare.co.zw/handle/123456789/241620
dc.languageEnglish
dc.languageالعربية
dc.language中文
dc.languageen
dc.languagear
dc.languagezh
dc.publisherWorld Health Organization
dc.rightsCC BY-NC-SA 3.0 IGO
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/3.0/igo
dc.rightsWorld Health Organization
dc.subjectCOVID-19
dc.subjectBetacoronavirus
dc.subjectDisease Outbreaks
dc.subjectCOVID-19 Vaccines
dc.subjectGuideline
dc.titleInterim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine: interim guidance, 17 March 2021
dc.typeTechnical Documents

Files

Collections

WHO IRIS